Quidel Receives CE Mark for Its Sofia Strep A Fluorescent Immunoassay Test
Quidel Corporation (NASDAQ: QDEL), a leading provider of diagnostic testing solutions, announced today that it has received the CE Mark for its Sofia Strep A FIA for use with its Sofia Analyzer. Sofia is the brand name for Quidel's next generation, immunoassay system. The Sofia Analyzer and Sofia Strep A FIA combine unique fluorescent chemistry, advanced lateral flow technology, and failure alert and fail-safe systems to ensure a reliable, objective, rapid and highly accurate diagnostic result. This press release follows closely on the recent announcement (October 26th) of the FDA clearance of the Sofia Analyzer and Sofia Influenza A+B FIA.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.